The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, according to a press release from manufacturer Biogen. Litifilimab (Biogen) is a ...
Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.
Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed improvements in cutaneous ...
Litifilimab is a humanized IgG1 monoclonal antibody targeting the BDCA2 receptor to reduce proinflammatory mediators in cutaneous lupus erythematosus.
Everyday Health on MSN
How to identify lupus rash and other skin symptoms of the condition
This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.
In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the ...
How would you treat a 30-year-old woman with systemic lupus erythematous (SLE) and lupus nephritis (LN) class 3 with new ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen McMahon, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results